BioHarvest Sciences Inc. (BHST) stock
BHSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.30−0.02 (-1.52%)
Close on Nov 20, 2026Market cap $29.47MP/E –Yield –
BioHarvest Sciences free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
For fiscal 2025 it was -$9.58M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$9.58M | – |
| FY2024 | Dec 31, 2024 | -$9.52M | – |
| FY2023 | Dec 31, 2023 | -$10.00M | – |
See a number that looks wrong?